Celine Halioua

@celinehalioua

Founder/CEO Celevity 🐶 Longevity Fund/Oxford gene therapy econ. Write to learn things. Equestrian 🐴

San Francisco, CA
Vrijeme pridruživanja: rujan 2017.

Tweetovi

Blokirali ste korisnika/cu @celinehalioua

Jeste li sigurni da želite vidjeti te tweetove? Time nećete deblokirati korisnika/cu @celinehalioua

  1. Prikvačeni tweet
    16. sij

    If you're interested in working on extending human (or dog) lifespan, you can apply-all to Longevity Fund portfolio companies here:

    Poništi
  2. proslijedio/la je Tweet
    4. velj

    Four years after Andreessen Horowitz raised its first bio fund, the shop is launching its third - and -focused fund. At $750 million, Bio Fund III is a16z’s biggest fund of its kind yet

    Poništi
  3. 3. velj
    Poništi
  4. 3. velj

    First drug for peanut allergy mitigation, although from what I can tell it is literally just peanut powder, with the innovation being the dosing regime + precision in comparison with allergists doing it in house. Which tbf is valuable when a wrong dose could lead to anaphylaxis

    Poništi
  5. 3. velj

    The cousin of the nefarious sock-eating daemon is the daemon that makes your Uber drive in the wrong direction, cancel twice, and stay in the slowest lane when you’re late to a meeting (but come immediately when you’re not quite ready yet)

    Poništi
  6. 3. velj

    Wholesome Sunday evenings in the Bay

    Poništi
  7. 2. velj

    My life has become a series of dog jokes Cc

    Poništi
  8. 1. velj

    “I spent all my bitcoin in 2015 on modafanil and a fake ID”

    Poništi
  9. proslijedio/la je Tweet
    31. sij

    Health officials in , racing to try to contain a fast-growing outbreak, are principally recording severe cases of disease, using a case definition that cannot capture patients with mild illness.

    Poništi
  10. proslijedio/la je Tweet
    31. sij

    A dozen #2019-nCoV vaccine development programs have been announced, five efforts to discover and develop therapeutic antibodies.

    Poništi
  11. 30. sij

    I'm loving the stealth swipe on Brex not being compatible with Apple Pay

    Poništi
  12. 30. sij

    Oxford? Conservative??? I never would have thought.... To be clear this is a hit on Ox, not

    Poništi
  13. 30. sij
    Poništi
  14. proslijedio/la je Tweet
    29. sij

    this is an amazing opportunity to work with + , don't miss it!

    Prikaži ovu nit
    Poništi
  15. 29. sij

    This is important bc one of the biggest arguments pharma makes against price control of new medicines by US Govt and quicker generic medicines access is that the cost to develop the new drug would be larger than the predicted ROI of the drug

    Poništi
  16. 29. sij

    Comparison of different US laws and their impact on patent exclusivity of new drugs (and therefore the ROI of the new drug for the pharma company). Innovation period = drug dev, monopoly=market approved, selling under patent, competitive=open to generics

    Poništi
  17. 29. sij

    Was speaking with a female founder friend this evening, and wow - the abuse, unprofessional and frankly rude behavior she has dealt with from investors is INSANE. Why is this ok? Still? The minute someone isn't a 'hot deal' or 'networked', everyone seems to lose common decency!

    Poništi
  18. 29. sij

    I have a science induced headache today

    Poništi
  19. proslijedio/la je Tweet
    28. sij

    Looking for great ML engineers who want to work in longevity - DM/email (ldeming.www@gmail.com) if interested!

    Poništi
  20. 27. sij

    Best histories/books on the development of specific drugs? You can find the scientific history of a drug relatively easy, but I’m talking about histories from w/in the companies, pivotal board meetings, the decisions that went into bringing the drug forward successfully (or not)

    Poništi
  21. 27. sij

    Any recs for the *perfect* white leather women’s sneaker? I go through them like 🔥 but still haven’t found a brand I like all that much

    Poništi

Čini se da učitavanje traje već neko vrijeme.

Twitter je možda preopterećen ili ima kratkotrajnih poteškoća u radu. Pokušajte ponovno ili potražite dodatne informacije u odjeljku Status Twittera.

    Možda bi vam se svidjelo i ovo:

    ·